Fundraising Fox
Visikol
AcquiredFounded 1985 · 69 employees on LinkedIn · 1 known investors
Find your way into Visikol
Sign up to see every warm intro you have to Visikol
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Visikol team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Mattek develops human-relevant in vitro research products, including lab-grown 3D human epithelial tissue models, banks of primary human cells, and cell culture dishes and plates optimized for cell growth and imaging. It serves life science researchers studying clinical outcomes through ethical, human-relevant alternatives.
Founders & leadership
Visikol was founded in 1985 by Michael Johnson.
Investors · 1
Non-dilutive funding · 6 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2021 | $1.6M |
| National Science Foundation | Phase II | 2019 | $750K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2018 | $280K |
| National Science Foundation | Phase I | 2018 | $225K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2018 | $224.5K |
| National Science Foundation | Phase I | 2016 | $225K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Visikol do?
- Mattek develops human-relevant in vitro research products, including lab-grown 3D human epithelial tissue models, banks of primary human cells, and cell culture dishes and plates optimized for cell growth and imaging. It serves life science researchers studying clinical outcomes through ethical, human-relevant alternatives.
- Who founded Visikol?
- Visikol was founded by Michael Johnson in 1985.
- Who are Visikol's investors?
- Visikol's investors include Foundation Venture Capital Group, LLC.